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Glucose reverses fasting-induced activation in the arcuate
nucleus of mice
Abstract
The hypothalamic arcuate nucleus is an important target for metabolic and hormonal signals controlling
food intake. As demonstrated by c-Fos studies, arcuate neurons are activated in food deprived mice,
while refeeding reverses the fasting-induced activation. To evaluate whether an increase in blood
glucose has an inhibitory effect on these neurons, we analyzed the c-Fos response to an intraperitoneal
glucose injection in fasted mice. This treatment increased blood glucose levels twofold and reduced 2h
food intake. Similar to refeeding, it also reversed the fasting-induced activation in the arcuate nucleus.
Therefore, an increase in blood glucose might be an important feeding-related signal acting via the
arcuate nucleus to oppose orexigenic stimuli.
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Abstract 
The hypothalamic arcuate nucleus is an important target for metabolic and hormonal 
signals controlling food intake. As demonstrated by c-Fos studies, arcuate neurons are 
activated in food deprived mice, while refeeding reverses the fasting-induced activation. To 
evaluate whether an increase in blood glucose has an inhibitory effect on these neurons, we 
analyzed the c-Fos response to an intraperitoneal glucose injection in fasted mice. This 
treatment increased blood glucose levels twofold and reduced 2h food intake. Similar to 
refeeding, it also reversed the fasting-induced activation in the arcuate nucleus. Therefore, 
an increase in blood glucose might be an important feeding-related signal acting via the 
arcuate nucleus to oppose orexigenic stimuli. 
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Introduction 
Peripheral metabolic cues that signal the availability of energy play a critical role in the 
control of food intake and energy homeostasis. Glucose, as the primary fuel source for 
neuronal tissue has a unique role among these signals. Blood glucose levels change in 
parallel with the nutritional status. The fluctuation of blood glucose levels is monitored by 
the brain that then initiates a behavioral response to adjust energy intake [1]. This is 
supported by the fact that changes in the availability of glucose have profound effects on 
food intake. While peripheral or central injection of glucose decreases food intake, insulin-
induced hypoglycemia or blockade of glucose utilization e.g. by 2-deoxy-glucose promotes 
food intake [1]. 
The arcuate nucleus is a key hypothalamic area in the control of food intake and energy 
homeostasis. It is a receptive area for numerous feeding-related signals, and contains 
neurons expressing orexigenic neuropeptide Y and anorectic, proopiomelanocortin-derived 
neuropeptides [2]. Glucosensitive neurons in the arcuate nucleus that change their firing 
rate in correlation with the ambient glucose concentration [3,4,5], are in an important 
position to influence energy balance. 
Interestingly, food deprivation induces c-Fos expression, a marker of neuronal activation, in 
the arcuate nucleus of mice [6,7,8,9]. This coincides with low circulating glucose levels. 
The fasting-induced neuronal activation in the arcuate nucleus is rapidly reversed by 
refeeding [8,10], suggesting that the postprandial rise in blood glucose might inhibit arcuate 
nucleus neurons. To our knowledge there is at present no in vivo evidence for such an 
inhibitory effect of increasing blood glucose levels on arcuate nucleus neurons. 
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Although c-Fos immunohistochemistry is a well-accepted method to demonstrate 
stimulatory effects, it is not well suited to directly investigate neuronal inhibition. In 
previous studies [10], we therefore used the reversal of fasting-induced c-Fos expression as 
an approach to characterize the inhibitory action of the anorectic peptide YY on arcuate 
nucleus neurons in vivo. In these studies administration of peptide YY, similar to refeeding, 
reduced c-Fos expression in the arcuate nucleus of fasted mice. This was consistent with an 
inhibitory effect of peptide YY on arcuate nucleus neurons in electrophysiological in vitro 
studies [10]. 
Based on the presumed glucosensitive function of the arcuate nucleus, we investigated 
whether a dose of glucose which reduces food intake also inhibits arcuate nucleus neurons, 
i.e. whether similar to refeeding and PPY administration, an intraperitoneal injection of 
glucose also reverses the fasting-induced c-Fos expression in this nucleus. Such an effect 
would implicate that a postprandial increase in blood glucose levels acts via the arcuate 
nucleus as an anorectic signal to oppose excitatory orexigenic stimuli. 
Materials 
Adult male C57Bl/6N (Charles Rivers, Germany) mice (mean body weight <30g) housed in 
individual cages in a temperature-controlled room (22°C) were used. The mice were kept 
under a 12 h light/dark cycle (lights off 9 am) and had free access to rodent chow (#3430; 
Kliba Nafag, Switzerland,) and water, except as indicated below. All animal procedures 
were approved by the Veterinary Office of the Canton of Zurich. 
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In the feeding studies, mice (n=14) were fasted for 12h during the light phase. At dark 
onset they received an intraperitoneal injection of either glucose (2.5g/kg in saline, 
0.1ml/10g; n=7) or saline (0.1ml/10g; n=7). Following injection mice were given access to 
chow. Food intake was measured 0.5, 1 and 2h later by manually weighing the feeding 
cups. The amount of food consumed was corrected for spillage. Student’s t-test was used to 
compare cumulative food intake between groups separately at each time point. P<0.05 was 
considered significant. Results are presented as means ± SEM.  
 
All animals used in the immunohistochemical studies were handled daily for at least three 
weeks before the experiments, according to the procedure recommended by Ryabinin et al. 
[11] to reduce handling- and injection-induced c-Fos expression. On the day of the 
experiment, mice (n=16) were fasted for 12h during the light phase. At dark onset, two 
groups of mice received an intraperitoneal injection of either glucose (2.5g/kg in saline; 
n=4) or saline (n=8) and remained fasted. One additional group of animals was injected 
with saline and was given access to food following injection (refed group, n=4). In all mice 
brains were removed two hours after dark onset and processed for c-Fos 
immunohistochemistry as described previously [12].  
c-Fos expressing arcuate nucleus neurons were identified according to the mouse brain atlas 
by Hof et al. [13]. Twenty eight corresponding, consecutive sections (20 µm) were 
manually counted for c-Fos positive arcuate nucleus cells in a blind fashion, in an area 
within 150 µm from the wall of the third ventricle. The mean value of the cell count/section 
of an individual animal was used for statistical analyses. Results were compared by one 
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way ANOVA, followed by Student-Newman-Keuls post-hoc test. Photomicrographs were 
taken by a digital camera (AxioCam, Carl Zeiss AG) and the fluorescent images were 
inverted to grayscale images.  
 
The effect of chow refeeding on blood glucose levels was measured in 12h fasted mice by 
tail bleeding. Eight mice were handled daily for at least two weeks before the experiments 
and were made familiar with the blood sampling procedure without an incision of the tail. 
All animals were food deprived for 12h during the light phase. At dark onset, a drop of 
blood was obtained by tail tip amputation from unanaesthetized mice and analyzed by a 
portable glucometer (Glucometer Elite, Bayer). Following blood collection, the animals 
were returned to their home cages and half of the animals (n=4) were given access to chow. 
The blood sampling was repeated 10, 20, 30, 45 and 60 minutes later. The same procedure 
was repeated in a cross-over design. On a separate occasion blood glucose was measured in 
the same mice under ad libitum feeding conditions at the onset of the dark phase. 
In another group of 12 h fasted mice, the effect of an intraperitoneal glucose injection on 
blood glucose levels was studied in a non cross-over design, but otherwise under the same 
experimental conditions as described above. After the baseline sample collection at lights 
off, mice were injected with glucose (2.5g/kg; n=7) or an equivalent volume of saline 
(n=5). Blood samples were taken at the same time points as above. Mice had no access to 
food during the experiment. Student’s t-test was used to compare blood glucose values 
between groups separately at each time point. 
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The portable glucometer used in the blood glucose measurements was validated by 
comparing its values with the results of a standard automated chemistry analyzer (Cobas 
Mira) by Student’s t-test (n=2-3 for each measurement). Glucose levels of blood samples of 
mice and of freshly prepared glucose solutions (2.77, 5.54 and 27.7 mmol/l in saline) were 
determined by both methods. Over the entire range of glucose concentrations the two 
methods yielded almost identical results (R=0.97; p<0.001). 
Results 
Glucose administration reduced cumulative food intake by 61% 0.5h (p<0.01), 53% 1h 
(p<0.001) and 38% 2h (p<0.01) after injection compared to the saline injected controls.  
 
In the immunohistochemical studies high c-Fos expression was found in the arcuate 
nucleus of fasted, saline injected mice (38 ± 8 cells/section). Refeeding of the mice for 2h 
reduced the number of c-Fos positive cells (4 ± 2 cells/section; p<0.05). The number of c-
Fos expressing neurons was also significantly lower in the arcuate nucleus of glucose 
injected animals (11 ± 5 cells/section) than in fasted, saline treated mice (p<0.05), but it did 
not differ significantly from that in the refed mice (Figure 1). 
 
Blood glucose levels in ad libitum fed mice were 7.9 ± 0.3 mmol/l when measured at the 
beginning of the dark phase. At the same time point 12h fasted mice had a significantly 
lower blood glucose level of 6.4 ± 0.3 mmol/l (p<0.01) (Figure 2A). When fasted mice 
were given access to chow, their blood glucose level rose significantly above that of fasted 
controls within 45 min of feeding, and remained elevated until the end of the blood 
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sampling period (Figure 2A). Glucose injection in fasted mice induced a more than twofold 
increase in blood glucose levels, reaching maximum levels at 20 min after injection (Figure 
2B).  
Discussion 
The arcuate nucleus is a receptive region for numerous peripheral feeding-related signals 
and its activity correlates with the nutritional status. In the present study, an increase in 
blood glucose, induced by exogenous glucose administration, reversed the fasting-induced 
c-Fos expression similar to chow refeeding. To our knowledge this is the first in vivo study 
to show an inhibitory effect of increased glucose levels in the arcuate nucleus. 
 
We presume that the increase in blood glucose levels following glucose injection had a 
direct inhibitory effect on glucosensitive neurons. The arcuate nucleus contains two 
different populations of glucosensitive neurons that reduce their spontaneous firing rate 
when the ambient glucose concentration rises within a discrete range [3,4]. According to 
this classification glucose-inhibited neurons decrease firing when extracellular glucose 
levels increase within the range of 0.1-5mM. These glucose-inhibited neurons might 
primarily monitor the glucose concentration in the brain parenchyma that is protected by 
the blood brain barrier and where the extracellular glucose concentration does not exceed 
5mM even in severe peripheral hyperglycemia [14]. Interestingly, most of the c-Fos 
positive neurons in the arcuate nucleus of fasted mice express neuropeptide Y [6] and these 
cells are glucose-inhibited neurons [4,17]. Hence, it is conceivable that a considerable 
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fraction of the neurons in which c-Fos expression was reversed following glucose injection 
in our study are the glucose-inhibited neuropeptide Y neurons. 
A distinct neuron population in the arcuate nucleus shows a similar response as the glucose-
inhibited cells, but only at higher glucose levels, above 5mM. Therefore, these cells were 
termed high glucose-inhibited neurons and were suggested to directly monitor blood 
glucose levels [3,4]. Chemicals in the blood seem to reach the axon terminals of arcuate 
neurons directly, through the fenestrated capillaries of the neighboring median eminence 
[15,16]. Although the neurochemical or functional properties of the high glucose-inhibited 
neurons are unknown, they may also have been affected by increasing blood glucose levels 
in our studies. 
 
Besides a direct effect of glucose on arcuate nucleus neurons, indirect mechanisms elicited 
by glucose administration are also likely to contribute to the inhibition of neuronal activity. 
Peripheral glucoreceptors in the hepatoportal system and splanchnic afferents modulate 
neuronal responses in hypothalamic areas following glucose application [18]. Furthermore, 
under physiological conditions an increase in blood glucose levels triggers e.g. insulin 
release. Insulin is believed to specifically inhibit orexigenic neuropeptide Y neurons [2]. 
However, it was not the aim of our study to distinguish between the effects of insulin and 
glucose on arcuate nucleus activity. Notably, under physiological postprandial conditions 
the neuronal effects of glucose and insulin occur in parallel and are therefore likely to act in 
concert in the modulation of neuronal activity. 
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The glucose dose used in our study induced a robust, but transient increase in blood glucose 
levels that exceeded the postprandial increase during chow refeeding under our 
experimental conditions. Nontheless, plasma glucose levels increase to similar values (15-
17 mmol/l) after a large meal [14]. Furthermore, in the glucose-injected mice, many 
feeding-related signals e.g. pre-absorptive factors and postprandial signals, triggered mainly 
by other nutrients, were absent. However, such signals are also likely to contribute to the 
reversal of arcuate nucleus activation following chow refeeding and might even interact. 
Synergistic inhibitory effects on the fasting-induced neuronal activation in the arcuate 
nucleus has been reported e.g. for leptin and CCK [9]. Thus in the refed state, i.e. in the 
presence of different interacting anorectic factors, a relatively small postprandial increase 
of plasma glucose levels might have a stronger inhibitory impact than a large dose of 
glucose injection in the fasted state. However, our results suggest that an increase in blood 
glucose alone is capable to suppress the activity of these cells. Nevertheless, even the high 
dose of glucose used in our study tended to reduce arcuate nucleus activity less than 
refeeding, although the difference between these groups did not reach statistical 
significance. The contribution of other feeding-related factors to the inhibition of arcuate 
nucleus neurons during refeeding is therefore very likely, but remains to be verified under 
the current experimental conditions.  
Our studies do not exclude hyperosmotic effects of the glucose injection. Equiosmolar 
solutions that are used to control for osmotic effects of glucose in vitro, e.g. mannitol, 
saline and urea are unlikely to represent adequate stimuli for in vivo studies. These solutes 
show different pharmacokinetics, e.g. different plasma clearance rates and brain transport 
mechanisms, and they induce different changes in plasma and cerebrospinal fluid 
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osmolarity [19,20,21]. Furthermore, to our knowledge there are no published studies 
supporting an osmosensitive function of the arcuate nucleus. For this reason and because 
the underlying neuromechanisms are well established, the specific (direct or indirect) 
inhibitory effects of glucose discussed above appear more plausible. 
 
Conclusion 
We conclude that a postprandial rise in glucose levels, in concert with other feeding-related 
signals, is an important inhibitory factor that opposes orexigenic stimuli activating arcuate 
nucleus neurons. This observation strongly supports the concept that an inhibitory action of 
glucose on arcuate nucleus neurons is involved in the glucose-dependent inhibition of food 
intake. 
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Figure legends 
 
Figure 1. Intraperitoneal injection of glucose (2.5g/kg), similar to refeeding with chow, 
reversed the fasting-induced neuronal activation in the hypothalamic arcuate nucleus (Arc) 
of mice. Photomicrographs of representative Arc sections immunostained for c-Fos of mice 
fasted for 14h and injected with saline (n=8; A), fasted for 12h and refed with chow (n=4; 
B) or fasted for 14h and injected with glucose (n=4; C) 2h before sacrifice. Scale bar = 100 
µm. Quantification of the c-Fos positive neurons in the Arc (D).  
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Figure 2. Blood glucose concentrations of mice. A: Following chow refeeding blood 
glucose values increased 45 and 60 minutes compared to mice which remained fasted 
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during the blood sampling period; * p<0.05. The baseline blood glucose values were lower 
in fasted mice than under ad libitum feeding conditions; # p<0.01. (n=8/group) B: Glucose 
application (2.5g/kg; ip, n=7) induced a rapid twofold increase in blood glucose levels 
compared to saline injection (n=5); *** p<0.001; * p<0.05. Student’s t-test. 
